SCHEMBL20483

SCHEMBL20483

[c]1cccc2cncnc12

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 0.47
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17511964 0.73 EGFR (0.41) EGFRPIK3CDPIK3CAKDM4E
SCHEMBL4054789 0.71 EGFR (0.37) EGFR
SCHEMBL19695 0.71 TSHR (0.42) KDM4E
SCHEMBL8311252 0.71 EGFR (0.38) EGFR
SCHEMBL17511898 0.71 EGFR (0.47) EGFRPIK3CDPIK3CAKDM4E
SCHEMBL17511899 0.71 EGFR (0.47) EGFRPIK3CDPIK3CAKDM4E
SCHEMBL27504674 0.70 TSHR (0.41) KDM4E
SCHEMBL21831938 0.70 TSHR (0.41) KDM4E
SCHEMBL27643306 0.70 TSHR (0.41) KDM4E
SCHEMBL27594643 0.70 TSHR (0.41) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5587 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11952376-B2 Substituted amino acids as integrin inhibitors PLIANT THERAPEUTICS, INC. (US) 2024-04-09 US claimed
WO-2024040497-A1 ANTIVIRAL COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 清华大学 2024-02-29 WO claimed
CN-113166119-B Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-05 CN claimed
WO-2023120742-A1 PHARMACEUTICAL COMPOSITION COMPRISING A QUINAZOLINE COMPOUND ASTELLAS PHARMA INC. (JP) 2023-06-29 WO claimed
WO-2023119677-A1 PHARMACEUTICAL COMPOSITION COMPRISING A QUINAZOLINE COMPOUND ASTELLAS PHARMA INC. (JP) 2023-06-29 WO claimed
WO-2023107490-A1 HETEROCYCLE-CONTAINING LONP1 INHIBITOR COMPOUNDS, USES AND METHODS PRETZEL THERAPEUTICS, INC. (US) 2023-06-15 WO claimed
CN-114957110-A Antiviral compound and preparation method and application thereof 清华大学 2022-08-30 CN claimed
CN-107709303-B Substituted imidazolium sulfanes and their use 科勒研究有限公司 2022-05-03 CN claimed
EP-3904352-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2021-11-03 EP claimed
CN-113166119-A Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-23 CN claimed
EP-0751944-A1 THIAZOLIDINES AND OXAZOLIDINES SUBSTITUTED BY A PYRIDINE RING AND THEIR USE AS HYPOGLYCEMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1997-01-08 EP claimed
WO-1996040142-A1 HETEROCYCLIC RING-FUSED PYRIMIDINE DERIVATIVES PFIZER INC. (US) 1996-12-19 WO claimed
US-5580870-A ANTICARCINOGENIC AGENTS ZENECA LIMITED (GB) 1996-12-03 US claimed
EP-0602851-B1 Quinazoline derivatives ZENECA LTD (GB) 1996-10-09 EP claimed
WO-1995026347-A1 THIAZOLIDINES AND OXAZOLIDINES SUBSTITUTED BY A PYRIDINE RING AND THEIR USE AS HYPOGLYCEMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1995-10-05 WO claimed
US-5401738-A Angiotensin antagonist, hypotensive, aldosteronism, cardiac insufficiency MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER (DE) 1995-03-28 US claimed
CN-1094043-A Quinazoline derivant ZENECA LTD (GB) 1994-10-26 CN claimed
EP-0602851-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1994-06-22 EP claimed
US-5280009-A Herbicide BASF AKTIENGESELLSCHAFT (DE) 1994-01-18 US claimed
EP-0167820-B1 PROCESS FOR THE PREPARATION OF OPTIONALLY SUBSTITUTED BENZ(C,D)-INDOL-2-ONES (NAPHTHOLACTAMES) BAYER AG (DE) 1989-04-26 EP claimed